tirzepatide supreme court Eli Lilly's Popular Weight Loss Drug, Zepbound, Is Getting a Price Cut FDA shakes up weight loss

Stop Zepbound in that case and contact your doctor immediately

It is a dual agonist that activates both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors simultaneously

Tirzepatide can be administered with or without meals, as food does not significantly affect its absorption or efficacy

The FDA-approved doses for Mounjaro and Zepbound escalate in 2.5 mg steps: 2.5, 5, 7.5, 10, 12.5, and 15 mg

Your answers help determine which program characteristics matter most for your specific situation: Have you discussed GLP-1 medication with your primary care provider or another clinician who knows your full medical history